Abstract
1. We have compared prejunctional alpha 2-adrenoceptors in rat and guinea-pig vas deferens and rat and guinea-pig atria with postjunctional alpha 2-adrenoceptors in human saphenous vein and human platelets employing the antagonists yohimbine and SK&F 104078 and other alpha 2-adrenoceptor antagonists. 2. Yohimbine was approximately 10 times more potent prejunctionally than SK&F 104078 at antagonizing the inhibition by the alpha 2-adrenoceptor agonist xylazine of stimulation-evoked contractions in rat and guinea-pig vas deferens, and at increasing stimulation-evoked release of tritium in rat and guinea-pig atria pre-incubated with [3H]-noradrenaline. 3. Yohimbine was approximately 10 times more potent postjunctionally than SK&F 104078 at antagonizing contractions to noradrenaline in human saphenous vein and at displacing [3H]-yohimbine binding in human platelet membranes. 4. For the antagonists yohimbine, SK&F 104078, prazosin, phentolamine, CH 38083 and urapidil, there was a significant correlation between prejunctional potency in rat vas deferens atrium and postjunctional potency in human platelet, although the correlation was improved by the omission of prazosin. 5. We have no evidence for differences between functional pre- and postjunctional alpha 2-adrenoceptors in the periphery, although these functional receptors may differ from the ligand binding site in the human platelet.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Buckley C., Curtin D., Walsh T., O'Malley K. Ageing and platelet alpha 2-adrenoceptors. Br J Clin Pharmacol. 1986 Jun;21(6):721–722. doi: 10.1111/j.1365-2125.1986.tb05238.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bylund D. B. Heterogeneity of alpha-2 adrenergic receptors. Pharmacol Biochem Behav. 1985 May;22(5):835–843. doi: 10.1016/0091-3057(85)90536-2. [DOI] [PubMed] [Google Scholar]
- Bylund D. B. Subtypes of alpha 2-adrenoceptors: pharmacological and molecular biological evidence converge. Trends Pharmacol Sci. 1988 Oct;9(10):356–361. doi: 10.1016/0165-6147(88)90254-4. [DOI] [PubMed] [Google Scholar]
- Connaughton S., Docherty J. R. Evidence that SK & F 104078 does not differentiate between pre- and postjunctional alpha 2-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1988 Oct;338(4):379–382. doi: 10.1007/BF00172113. [DOI] [PubMed] [Google Scholar]
- Daly R. N., Sulpizio A. C., Levitt B., DeMarinis R. M., Regan J. W., Ruffolo R. R., Jr, Hieble J. P. Evidence for heterogeneity between pre- and postjunctional alpha-2 adrenoceptors using 9-substituted 3-benzazepines. J Pharmacol Exp Ther. 1988 Oct;247(1):122–128. [PubMed] [Google Scholar]
- Docherty J. R., Hyland L. Evidence for neuro-effector transmission through postjunctional alpha 2-adrenoceptors in human saphenous vein. Br J Pharmacol. 1985 Feb;84(2):573–576. doi: 10.1111/j.1476-5381.1985.tb12942.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Docherty J. R. Pertussis toxin and pre-junctional alpha 2-adrenoreceptors in rat heart and vas deferens. J Auton Pharmacol. 1988 Sep;8(3):197–201. doi: 10.1111/j.1474-8673.1988.tb00183.x. [DOI] [PubMed] [Google Scholar]
- Docherty J. R., Warnock P. An investigation of alpha-adrenoceptor responsiveness in the vas deferens of spontaneously hypertensive rats. Br J Pharmacol. 1985 Oct;86(2):327–333. doi: 10.1111/j.1476-5381.1985.tb08900.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eskinder H., Hillard C. J., Olinger G. N., Christensen C. W., Baker J. E., Warltier D. C., Gross G. J. Alpha adrenoceptor subtypes and receptor reserve in human versus canine saphenous vein: sensitivity to blockade by nitroglycerin. J Pharmacol Exp Ther. 1988 Dec;247(3):941–948. [PubMed] [Google Scholar]
- Hieble J. P., Sulpizio A. C., Nichols A. J., Willette R. N., Ruffolo R. R., Jr Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors. J Pharmacol Exp Ther. 1988 Nov;247(2):645–652. [PubMed] [Google Scholar]
- Kobilka B. K., Matsui H., Kobilka T. S., Yang-Feng T. L., Francke U., Caron M. G., Lefkowitz R. J., Regan J. W. Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor. Science. 1987 Oct 30;238(4827):650–656. doi: 10.1126/science.2823383. [DOI] [PubMed] [Google Scholar]
- Murphy T. J., Bylund D. B. Characterization of alpha-2 adrenergic receptors in the OK cell, an opossum kidney cell line. J Pharmacol Exp Ther. 1988 Feb;244(2):571–578. [PubMed] [Google Scholar]
- Musgrave I., Marley P., Majewski H. Pertussis toxin does not attenuate alpha 2-adrenoceptor mediated inhibition of noradrenaline release in mouse atria. Naunyn Schmiedebergs Arch Pharmacol. 1987 Sep;336(3):280–286. doi: 10.1007/BF00172679. [DOI] [PubMed] [Google Scholar]
- Müller-Schweinitzer E. Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins. Naunyn Schmiedebergs Arch Pharmacol. 1984 Oct;327(4):299–303. doi: 10.1007/BF00506240. [DOI] [PubMed] [Google Scholar]
- Ruffolo R. R., Jr, Sulpizio A. C., Nichols A. J., DeMarinis R. M., Hieble J. P. Pharmacologic differentiation between pre- and postjunctional alpha 2-adrenoceptors by SK&F 104078. Naunyn Schmiedebergs Arch Pharmacol. 1987 Oct;336(4):415–418. doi: 10.1007/BF00164875. [DOI] [PubMed] [Google Scholar]
- Steen S., Sjöberg T., Skärby T., Norgren L., Andersson K. E. The postjunctional alpha-adrenoceptors of the human saphenous vein. Acta Pharmacol Toxicol (Copenh) 1984 Nov;55(5):351–357. doi: 10.1111/j.1600-0773.1984.tb01994.x. [DOI] [PubMed] [Google Scholar]
- Vizi E. S., Harsing L. G., Jr, Gaal J., Kapocsi J., Bernath S., Somogyi G. T. CH-38083, a selective, potent antagonist of alpha-2 adrenoceptors. J Pharmacol Exp Ther. 1986 Aug;238(2):701–706. [PubMed] [Google Scholar]